InflaRx ( (IFRX)) has issued an update. On June 30, 2026, InflaRx said it is reviewing how to broaden its development and registration strategy for ANCA-associated vasculitis (AAV) in Europe. The move ...
InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV) The Company is assessing the most efficient ...
InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV)The Company is assessing the most efficient de ...
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and CSL announced today that the European Medicines Agency's (EMA) ...
Researchers at IIT Kanpur, led by Professor Arun K Shukla, have uncovered the molecular basis underlying the atypical signalling behaviour of C5aR2, an immune receptor that has puzzled scientists for ...
IIT Kanpur researchers solve mystery of atypical drug target receptor ...
Recommendation follows an Article 20 non-pharmacovigilance procedure Patients currently on TAVNEOS treatment should consult their treating physician ST. GALLEN, Switzerland, June 26, 2026 /PRNewswire/ ...
Scientists have spotted a new variety of riled-up microglia that drives swelling in the human brain. In the November 18 Neuron, researchers from China led by Haixiao Liu, Shunnan Ge, and Yan Qu at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results